SOPH - SOPHiA GENETICS SA

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-87,449
-87,449
-73,675
-39,339
-33,791
Depreciation & amortization
5,571
5,571
3,609
2,390
1,913
Deferred income taxes
-1,292
-1,292
-1,597
-763
-447
Stock based compensation
13,613
13,613
8,514
1,359
717
Change in working capital
-1,273
-1,273
6,120
3,816
-1,620
Accounts receivable
1,332
1,332
1,806
1,118
-4,352
Inventory
-200
-200
-2,336
536
-862
Accounts Payable
-1,428
-1,428
8,980
-185
5,603
Other working capital
-80,474
-80,474
-64,610
-34,934
-34,713
Other non-cash items
-685
-685
208
1,128
987
Net cash provided by operating activites
-70,093
-70,093
-57,939
-31,730
-31,680
Cash flows from investing activities
Investments in property, plant and equipment
-10,381
-10,381
-6,671
-3,204
-3,033
Purchases of investments
-26,179
-26,179
-72,141
-21,119
0
Sales/Maturities of investments
78,533
78,533
21,878
-
0
Net cash used for investing activites
41,973
41,973
-56,934
-24,323
-3,033
Cash flows from financing activities
Debt repayment
-2,316
-2,316
-4,085
-17,509
-2,783
Common stock issued
0
0
231,311
107,643
0
Other financing activites
-
-
6,020
-
-
Net cash used privided by (used for) financing activities
-1,568
-1,568
237,773
107,045
-1,023
Net change in cash
-29,688
-29,688
122,900
50,992
-35,736
Cash at beginning of period
192,962
192,962
74,625
18,069
53,907
Cash at end of period
161,305
161,305
192,962
74,625
18,069
Free Cash Flow
Operating Cash Flow
-70,093
-70,093
-57,939
-31,730
-31,680
Capital Expenditure
-10,381
-10,381
-6,671
-3,204
-3,033
Free Cash Flow
-80,474
-80,474
-64,610
-34,934
-34,713